GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the recipient of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 8,785 shares, a decline of 35.4% from the June 15th total of 13,609 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily volume of 15,506 shares, the days-to-cover ratio is presently 0.6 days.
GMO U.S. Value ETF Stock Performance
GMO U.S. Value ETF stock traded down $0.04 during trading hours on Friday, reaching $31.05. 4,610 shares of the company’s stock traded hands, compared to its average volume of 17,165. GMO U.S. Value ETF has a fifty-two week low of $24.79 and a fifty-two week high of $31.29. The firm has a market capitalization of $96.25 million, a price-to-earnings ratio of 12.08 and a beta of 0.65. The firm’s 50 day moving average is $30.13 and its 200-day moving average is $29.14.
Hedge Funds Weigh In On GMO U.S. Value ETF
A number of hedge funds and other institutional investors have recently bought and sold shares of GMOV. HighTower Advisors LLC boosted its stake in GMO U.S. Value ETF by 1.8% in the fourth quarter. HighTower Advisors LLC now owns 123,110 shares of the company’s stock valued at $3,384,000 after acquiring an additional 2,182 shares during the last quarter. Fifth Third Bancorp bought a new stake in shares of GMO U.S. Value ETF during the 1st quarter valued at $84,000. Fund Evaluation Group LLC lifted its stake in shares of GMO U.S. Value ETF by 7.4% in the 4th quarter. Fund Evaluation Group LLC now owns 50,500 shares of the company’s stock valued at $1,388,000 after purchasing an additional 3,500 shares during the period. Essential Partners LLC boosted its position in shares of GMO U.S. Value ETF by 8.6% in the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after purchasing an additional 4,774 shares during the last quarter. Finally, Legacy Capital Wealth Partners LLC boosted its position in shares of GMO U.S. Value ETF by 6.8% in the 4th quarter. Legacy Capital Wealth Partners LLC now owns 96,504 shares of the company’s stock worth $2,653,000 after purchasing an additional 6,156 shares during the last quarter.
GMO U.S. Value ETF Company Profile
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
See Also
- Five stocks we like better than GMO U.S. Value ETF
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
